Expanded Studies on the SCAPIS Stockholm Reexamination Cohort
Recruiting · NCT07476703 · Observational (researchers observe without assigning treatment) · Lead sponsor: Danderyd Hospital
View the official record on ClinicalTrials.gov →Interventions studied
What this trial is about
The Swedish CArdioPulmonary bioImage Study (SCAPIS) is a unique, large-scale national research initiative involving 30,000 randomly selected individuals aged 50-64, recruited between 2014 and 2018. The study is a collaborative effort among six university hospitals across Sweden. A follow-up study, SCAPIS 2, is conducted for half of the original participants. In Stockholm, 2,500 individuals will be re-examined at Danderyd University Hospital and Karolinska Institutet. SCAPIS 2 includes a core set of examinations involving blood sampling, questionnaires, and imaging. In addition to these, complementary local investigations are conducted to enable more detailed research questions. This protocol describes the additional studies conducted in the Stockholm cohort. All complementary assessments aim to identify risk factors for current and future lung, liver, and cardiovascular diseases.: EXTENDED SAMPLING: Saliva and Blood Samples with Blood Cell Isolation. EXTENDED QUESTIONNAIRES: Dyspnea, Sleep, Respiratory Infections, and Dental Health. EXTENDED IMAGING AND PHYSIOLOGICAL MEASUREMENTS Cardiac Ultrasound and Abdominal Aortic Measurements. Liver Elastography. Vascular Stiffness by cuff-based pulse wave analysis and Photoplethysmography (PPG). Valvular and Vascular Calcification by CT imaging.
Who can take part
Inclusion criteria
- Subjects already included in the main / general SCAPIS reexamination study in Stockholm.
Exclusion criteria
- Inability to provide consent.
Where it is running
1 location listed.
- Cardiovascular Research Lab, Dept Cardiology, Danderyd University Hospital - Stockholm, Sweden